Proof of Biological Activity of SAR100842 in Systemic Sclerosis

NCT01651143 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Sclerosis

Interventions

DRUG: SAR100842
DRUG: Placebo (for SAR100842)

Sponsor

Sanofi